Morgan Stanley Call 100 SY1 20.09.../ DE000ME1A9X3 /
05/06/2024 12:11:50 | Chg.+0.030 | Bid13:05:58 | Demandez à13:05:58 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
0.770EUR | +4.05% | 0.770 Bid taille: 80,000 |
0.780 Ask la taille: 80,000 |
SYMRISE AG INH. O.N. | 100.00 EUR | 20/09/2024 | Call |
GlobeNewswire
13:35
Axsome Therapeutics Settles Sunosi® (solriamfetol) Patent Litigation with Unichem Laboratories
Newsfile Corp
13:30
Appia Begins Uranium Exploration Season with Ground Reconnaissance at "Eastside" Project, Saskatchew...
GlobeNewswire
13:30
Hydreight in Partnership with DSV Global and VS Digital Health Launches Telemedicine Solution That H...
GlobeNewswire
13:30
Ocean Power Technologies Awarded Contract for Immediate Delivery of Unmanned Surface Vehicle to Offs...
GlobeNewswire
13:30
Bread Financial™ to Participate in the Morgan Stanley U.S. Financials, Payments & Commercial Real Es...
GlobeNewswire
13:30
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
13:28
Ollie’s Bargain Outlet Announces Executive Promotions and Appointments as Part of Anticipated Leader...
GlobeNewswire
13:05
Eldorado Gold Announces Election of Directors and Voting Results from Annual Meeting of Shareholders
GlobeNewswire
13:05
Y-mAbs Deepens Radiopharmaceutical Leadership with Appointment of Norman LaFrance, M.D. as Chief Dev...
GlobeNewswire
13:01
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
13:00
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conferenc...
GlobeNewswire
13:00
G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page